24

Apr

2017

OptumRx : Kaiser Permanente - High Dose Morphine Equivalent Dose (MED) DUR Soft Rejects Instructions for Overriding the DUR

Pharmacists have the ability to override High Dose MED soft reject DUR by using appropriate DUR/PPS Reason, Professional, and Result codes.

7

Apr

2017

MagellanRx Health: Opioid (MED) Program Update

Effective April 1st 2017

Dear Pharmacy Partner,

Below is an update from our prior January 6, 2017 email communication regarding changes to our Opioid Morphine Equivalent Dose (MED) program that placed edits at the point of sale. 

28

Dec

2016

Argus: Bulletin Communication #44MG16 - 2017 Medicare Opioid Overutilization Edits and POS Override

Effective January 1st 2017

To comply with new regulations from the Centers for Medicaid and Medicare Services (CMS), most Medicare Part D Plans and some commercial plans will be implementing new edits to help manage opioid use within their Medicare populations.

*Please see attached PDF for more information.

13

Dec

2016

Prime Therapeutics: BlueCross BlueShield of Illinois - Medicaid Processing Update

Effective January 1st 2017

Dear Valued Provider,
Effective January 1, 2017, Blue Cross Community Integrated Care Plan (ICP) and Blue Cross Community Family Health Plan (FHP) Covered Persons will be subject to a Morphine Equivalent Dose (MED) quantity limit. Please see the attachments below for further processing instructions.

If you have questions regarding claims processing, please call the Prime Contact Center at 800.821.4795.

Sincerely,
Pharmacy Network Management
Prime Therapeutics LLC


Prime Therapeutics Contracting Fax number: 877.823.6373



*Please see attached PDF for more information.

1

Dec

2016

MedImpact Healthcare Systems, Inc. - Notice of New Point of Sale Edit Functionality

Effective January 1st 2017

Dear Network Pharmacy Partner,

Please be advised that, effective 1/1/2017, MedImpact will be implementing new POS edit functionality to support mandatory 2017 CMS requirements for Medicare Part D claims processing.


*Please see attached PDF for more information.

12